• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症损伤的量化:对现行量表的讨论。

Quantification of impairment in MS: discussion of the scales in use.

作者信息

Amato M P, Ponziani G

机构信息

Department of Neurology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy.

出版信息

Mult Scler. 1999 Aug;5(4):216-9. doi: 10.1177/135245859900500404.

DOI:10.1177/135245859900500404
PMID:10467378
Abstract

Accurate, efficient measurement of disease status has become a key issue in MS clinical practice and research. Despite some perceived problems, the Expanded Disability Status Scale (EDSS) remains the most widely used comprehensive measure of impairment. There is also a place for more restricted scales of impairment which focus on some aspects of neurological function in more detail than the EDSS e.g. measures of ambulation, arm function and cognitive function. Improvements in scales of impairment in the future is likely to result from the use of more quantitative tests of selected components of the neurological examination.

摘要

准确、高效地测量疾病状态已成为多发性硬化症临床实践和研究中的关键问题。尽管存在一些公认的问题,但扩展残疾状态量表(EDSS)仍然是最广泛使用的综合损伤测量方法。对于更具局限性的损伤量表也有需求,这些量表比EDSS更详细地关注神经功能的某些方面,例如步行、手臂功能和认知功能的测量。未来损伤量表的改进可能源于对神经检查选定组成部分使用更多定量测试。

相似文献

1
Quantification of impairment in MS: discussion of the scales in use.多发性硬化症损伤的量化:对现行量表的讨论。
Mult Scler. 1999 Aug;5(4):216-9. doi: 10.1177/135245859900500404.
2
Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.Kurtkze 扩展残疾状况量表与功能独立性测量的比较:多发性硬化症相关残疾的测量。
Disabil Rehabil. 2013;35(22):1877-84. doi: 10.3109/09638288.2013.766269. Epub 2013 Apr 19.
3
Multiple sclerosis: assessment of disability and disability scales.多发性硬化症:残疾评估与残疾量表
J Neurol. 1998 Apr;245(4):189-96. doi: 10.1007/s004150050204.
4
The MS Impairment Scale: a pragmatic approach to the assessment of impairment in patients with multiple sclerosis.多发性硬化症损伤量表:一种评估多发性硬化症患者损伤情况的实用方法。
Mult Scler. 1997 Feb;3(1):31-42. doi: 10.1177/135245859700300104.
5
A questionnaire to assess neurological impairment in multiple sclerosis.一份用于评估多发性硬化症神经功能缺损的问卷。
Mult Scler. 1998 Oct;4(5):444-51. doi: 10.1177/135245859800400508.
6
Clinical outcome measures in multiple sclerosis.多发性硬化症的临床结局指标
Handb Clin Neurol. 2014;122:393-404. doi: 10.1016/B978-0-444-52001-2.00016-9.
7
MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment.MS-CANE:一种用于多发性硬化症患者神经学评估的计算机辅助仪器:增强扩展残疾状态量表(EDSS)评估的可靠性
Mult Scler. 2000 Oct;6(5):355-61. doi: 10.1177/135245850000600511.
8
Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.与扩展残疾状况量表相比,多发性硬化症损伤量表的反应性。
Mult Scler. 2005 Feb;11(1):81-4. doi: 10.1191/1352458505ms1120oa.
9
Clinical scoring methods for multiple sclerosis.
Ann Neurol. 1994;36 Suppl:S80-5. doi: 10.1002/ana.410360718.
10
Depression, coping and level of neurological impairment in multiple sclerosis.多发性硬化症中的抑郁、应对方式与神经功能缺损程度
Mult Scler. 1997 Aug;3(4):254-8. doi: 10.1177/135245859700300408.

引用本文的文献

1
Speech Discrimination Tasks: A Sensitive Sensory and Cognitive Measure in Early and Mild Multiple Sclerosis.言语辨别任务:早期和轻度多发性硬化症中一种敏感的感觉和认知测量方法。
Front Neurosci. 2020 Dec 23;14:604991. doi: 10.3389/fnins.2020.604991. eCollection 2020.
2
Neurostatus and EDSS Calculation with Cases.神经状态及扩展残疾状态量表(EDSS)计算与病例
Noro Psikiyatr Ars. 2018;55(Suppl 1):S80-S83. doi: 10.29399/npa.23412.
3
What We Learned from The History of Multiple Sclerosis Measurement: Expanded Disability Status Scale.我们从多发性硬化症测量史中学到了什么:扩展残疾状态量表。
Noro Psikiyatr Ars. 2018;55(Suppl 1):S69-S75. doi: 10.29399/npa.23343.
4
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview.继发进展型多发性硬化症的药物治疗:概述。
CNS Drugs. 2018 Jun;32(6):499-526. doi: 10.1007/s40263-018-0538-0.
5
Linear Parameter Varying Identification of Dynamic Joint Stiffness during Time-Varying Voluntary Contractions.时变自主收缩过程中动态关节刚度的线性参数变化识别
Front Comput Neurosci. 2017 May 19;11:35. doi: 10.3389/fncom.2017.00035. eCollection 2017.
6
Quantitative measures of walking and strength provide insight into brain corticospinal tract pathology in multiple sclerosis.步行和力量的定量测量有助于深入了解多发性硬化症患者的脑皮质脊髓束病变情况。
Neuroimage Clin. 2017 Feb 20;14:490-498. doi: 10.1016/j.nicl.2017.02.006. eCollection 2017.
7
Secondary Progressive Multiple Sclerosis: Definition and Measurement.继发进展型多发性硬化症:定义与测量
CNS Drugs. 2016 Jun;30(6):517-26. doi: 10.1007/s40263-016-0340-9.
8
A predictive model for corticosteroid response in individual patients with MS relapses.多发性硬化症复发个体患者皮质类固醇反应的预测模型。
PLoS One. 2015 Mar 18;10(3):e0120829. doi: 10.1371/journal.pone.0120829. eCollection 2015.
9
Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.对多发性硬化症患者的扩展残疾状况量表(EDSS)和多发性硬化症功能综合评定量表(MSFC)进行系统文献回顾和有效性评估。
BMC Neurol. 2014 Mar 25;14:58. doi: 10.1186/1471-2377-14-58.
10
Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.验证一种新的基于网络的方法,以捕捉多发性硬化症中的疾病进展结果。
J Neurol. 2013 Oct;260(10):2505-10. doi: 10.1007/s00415-013-7004-1. Epub 2013 Jun 27.